FINHUB Insights

ZBH · Q2 FY26 · Apr 1 – Jun 30, 2026

Zimmer Biomet Q2 FY26: where the revenue came from and where it went

Zimmer Biomet Q2 FY26: revenue $2.2B (+5% year over year). Net profit $0.20B. Largest cohort Knees $0.8B. The whole income statement as a sankey diagram from the SEC filing.

Period
Apr 1 – Jun 30, 2026
Reported
Aug 5, 2026 10-Q
Sankey diagram of Zimmer Biomet's income statement for Q2 FY26: revenue of $2.18 billion splits into segments and flows out into costs, taxes and net profit.

Tap the diagram to enlarge · figures in billions of dollars

Revenue$2.18B +5% year over year
Gross profit$1.54B 71% margin
Operating profit$0.33B 15% margin
Net profit$0.20B 9% margin

The numbers

All figures in billions of U.S. dollars, for Q2 FY26 (period ends Jun 30, 2026).
ItemValueShare of revenueYear over year
Revenue 2.18 100% +5%
Knees 0.83 38% +0%
SET 0.59 27% +6%
Hips 0.56 26% +5%
Technology & data bone 0.20 9% +21%
Cost of revenue−0.6429%
Gross profit1.5471% margin−1pp
SG&A−0.9041%+2pp
Other−0.3215%+0pp
Operating profit0.3315% margin+1pp
Tax−0.06
Interest & other costs−0.07
Net profit0.209%+2pp
Filing on EDGAR More quarters of ZBH

Source of the numbers: structured XBRL data from the filing (10-Q). The diagram is generated automatically and checked against EDGAR before release. How we calculate it → About and methodology.